Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure

JDA Tyndall, B Pfeiffer, G Abbenante… - Chemical …, 2005 - ACS Publications
G protein-coupled receptors (GPCRs) are seven transmembrane helical bundle proteins
(Figure 1) found on the surface of all cells. 1-3 They mediate cellular responses to a diverse …

International union of basic and clinical pharmacology. XCII. Urotensin II, urotensin II–related peptide, and their receptor: From structure to function

H Vaudry, J Leprince, D Chatenet, A Fournier… - Pharmacological …, 2015 - ASPET
Urotensin II (UII) is a cyclic neuropeptide that was first isolated from the urophysis of teleost
fish on the basis of its ability to contract the hindgut. Subsequently, UII was characterized in …

The Concise Guide to PHARMACOLOGY 2013/14: G protein‐coupled receptors

SPH Alexander, HE Benson… - British journal of …, 2013 - Wiley Online Library
Abstract The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of
the key properties of over 2000 human drug targets with their pharmacology, plus links to an …

Urotensin II: its function in health and its role in disease

KL Ong, KSL Lam, BMY Cheung - Cardiovascular drugs and therapy, 2005 - Springer
Abstract Urotensin II (U-II) is the most potent vasoconstrictor known, even more potent than
endothelin-1. It was first isolated from the fish spinal cord and has been recognized as a …

From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function

SA Douglas, D Dhanak, DG Johns - Trends in pharmacological sciences, 2004 - cell.com
The identification of a human homolog of urotensin-II (U-II) and a novel, specific G-protein-
coupled receptor by Ames et al. in 1999 changed the perception that the U-II isopeptide …

Targeting “undruggable” proteins: Design of synthetic cyclopeptides

A Russo, C Aiello, P Grieco… - Current Medicinal …, 2016 - ingentaconnect.com
The development of synthetic macrocycles represents a powerful approach toward the
identification of new protein binders or inhibitors of Protein-Protein Interactions (PPI) which …

Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

R Patacchini, P Santicioli, S Giuliani… - British journal of …, 2003 - Wiley Online Library
In this study we describe the ability of two human urotensin‐II (hU‐II) derivatives [Pen5,
Orn8] hU‐II (4–11) and [Pen5, DTrp7, Orn8] hU‐II (4–11)(urantide) to block hU‐II‐induced …

[HTML][HTML] Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials

P Grieco, I Gomez-Monterrey - Archives of biochemistry and biophysics, 2019 - Elsevier
Several peptides play an important role in physiological and pathological conditions into the
cardiovascular system. In addition to well-known vasoactive agents such as angiotensin II …

Structure–activity relationships and structural conformation of a novel urotensin II-related peptide

D Chatenet, C Dubessy, J Leprince, C Boularan… - Peptides, 2004 - Elsevier
Urotensin II (UII) has been described as the most potent vasoconstrictor peptide and
recognized as the endogenous ligand of the orphan G protein-coupled receptor GPR14 …

Urotensin II Receptor Modulation with 1, 3, 4-Benzotriazepin-2-one Tetrapeptide Mimics

X Wei, S Diarra, A Douchez… - Journal of Medicinal …, 2023 - ACS Publications
Urotensin II receptor (UT) modulators that differentiate the effects of the endogenous cyclic
peptide ligands urotensin II (UII) and urotensin II-related peptide (URP) offer potential for …